Search research articles
Contact Us
Filters
Showing results (31-40 of 133) with videos related to
Page
of 14
Sort By:
NPJ Precision Oncology
|
July 2, 2025
Spontaneous tumor regression and immunotherapy response demonstrate clonal T-cell expansion in Merkel cell carcinoma
Patrick Hallaert, John W Roman, Mairead Baker, et al.
Nature Methods
|
October 27, 2022
Netie: inferring the evolution of neoantigen-T cell interactions in tumors
Tianshi Lu, Seongoh Park, Yi Han, et al.
Medcomm
|
June 6, 2024
The combination of tumor mutational burden and T-cell receptor repertoire predicts the response to immunotherapy in patients with advanced non-small cell lung cancer
Yalun Li, Liyan Ji, Yingqian Zhang, et al.
Frontiers in Immunology
|
April 29, 2021
Response to Hypomethylating Agents in Myelodysplastic Syndrome Is Associated With Emergence of Novel TCR Clonotypes
Hussein A Abbas, Patrick K Reville, Xianli Jiang, et al.
Nature Machine Intelligence
|
August 25, 2022
Deep learning-based prediction of the T cell receptor-antigen binding specificity
Tianshi Lu, Ze Zhang, James Zhu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 23, 2019
Combination anti-CTLA-4 plus anti-PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies
Spencer C Wei, Nana-Ama A S Anang, Roshan Sharma, et al.
Cancers
|
June 2, 2021
Intertumoral Genetic Heterogeneity Generates Distinct Tumor Microenvironments in a Novel Murine Synchronous Melanoma Model
Shuyang S Qin, Booyeon J Han, Alyssa Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2024
Phase I/II Study of the Aurora Kinase A Inhibitor Alisertib and Pembrolizumab in Refractory, Rb-Deficient Head and Neck Squamous Cell Carcinomas
Faye M Johnson, Madison P O'Hara, Lacin Yapindi, et al.
Nature Communications
|
February 8, 2024
Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy
Jiefei Han, Yiting Dong, Xiuli Zhu, et al.
Nature Communications
|
February 24, 2025
Author Correction: Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy
Jiefei Han, Yiting Dong, Xiuli Zhu, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 133) with videos related to
Sort By:
Page
of 14
NPJ Precision Oncology
|
July 2, 2025
Spontaneous tumor regression and immunotherapy response demonstrate clonal T-cell expansion in Merkel cell carcinoma
Patrick Hallaert, John W Roman, Mairead Baker, et al.
Nature Methods
|
October 27, 2022
Netie: inferring the evolution of neoantigen-T cell interactions in tumors
Tianshi Lu, Seongoh Park, Yi Han, et al.
Medcomm
|
June 6, 2024
The combination of tumor mutational burden and T-cell receptor repertoire predicts the response to immunotherapy in patients with advanced non-small cell lung cancer
Yalun Li, Liyan Ji, Yingqian Zhang, et al.
Frontiers in Immunology
|
April 29, 2021
Response to Hypomethylating Agents in Myelodysplastic Syndrome Is Associated With Emergence of Novel TCR Clonotypes
Hussein A Abbas, Patrick K Reville, Xianli Jiang, et al.
Nature Machine Intelligence
|
August 25, 2022
Deep learning-based prediction of the T cell receptor-antigen binding specificity
Tianshi Lu, Ze Zhang, James Zhu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 23, 2019
Combination anti-CTLA-4 plus anti-PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies
Spencer C Wei, Nana-Ama A S Anang, Roshan Sharma, et al.
Cancers
|
June 2, 2021
Intertumoral Genetic Heterogeneity Generates Distinct Tumor Microenvironments in a Novel Murine Synchronous Melanoma Model
Shuyang S Qin, Booyeon J Han, Alyssa Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2024
Phase I/II Study of the Aurora Kinase A Inhibitor Alisertib and Pembrolizumab in Refractory, Rb-Deficient Head and Neck Squamous Cell Carcinomas
Faye M Johnson, Madison P O'Hara, Lacin Yapindi, et al.
Nature Communications
|
February 8, 2024
Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy
Jiefei Han, Yiting Dong, Xiuli Zhu, et al.
Nature Communications
|
February 24, 2025
Author Correction: Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy
Jiefei Han, Yiting Dong, Xiuli Zhu, et al.
Page
of 14